ARTERIUS
Arterius Limited is developing a novel next-generation polymer-based Bio-resorbable Coronary Scaffold (BRS), more commonly known as a ‘stent’. The bio-resorbable attribute allows the stent to dissolve over time, typically 12–24 months, before being absorbed by the body. Therefore, there is no requirement to physically remove the stent. The Company’s solution offers a huge opportunity to minimise the frequency of surgery or medical interventions and could give patients a better post-operative quality of life.
ARTERIUS
Social Links:
Industry:
Biotechnology Health Care Life Science Medical Medical Device Pharmaceutical
Founded:
2009-01-01
Address:
Leeds, Leeds, United Kingdom
Country:
United Kingdom
Website Url:
http://www.arterius.co.uk
Total Employee:
1+
Status:
Active
Contact:
0113 4264300
Email Addresses:
[email protected]
Total Funding:
349 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Arterial Remodeling Technologies
Arterial Remodeling Technologies develops bioresorbable peripheral and coronary polymer stents.
Mumo
Share your secure health information anywhere in the world with anyone you want.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Employees Featured
Founder
Investors List
Innovate UK
Innovate UK investment in Grant - Arterius
Deepbridge Capital
Deepbridge Capital investment in Seed Round - Arterius
Official Site Inspections
http://www.arterius.co.uk
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
